Cognition Therapeutics (CGTX) EPS (Basic) (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly EPS (Basic) of -$0.1 for Q1 2026, up 55.56% year-over-year from -$0.06 in Q1 2025, and up 47.3% quarter-over-quarter from -$0.19 in Q4 2025.
Cognition Therapeutics (CGTX) EPS (Basic) (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported EPS (Basic) for 7 consecutive years, with -$0.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 55.56% year-over-year to -$0.1; the TTM figure through Mar 2026 stood at -$0.49 (up 45.27% YoY), while the FY2025 annual figure was -$1.15, down 34.73% from the prior year.
- EPS (Basic) grew to -$0.1 in Q1 2026 per CGTX's latest filing, from -$0.19 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.09 in Q3 2025 and bottomed at -$0.52 in Q4 2022.
- Historically, EPS (Basic) has averaged -$0.29 across 5 years, with a median of -$0.25 in 2022.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 96.46% — and 2024, when it slumped 147.12%.
- Cognition Therapeutics' EPS (Basic) stood at -$0.52 in 2022, then increased by 2.13% to -$0.51 in 2023, then soared by 46.56% to -$0.27 in 2024, then jumped by 30.47% to -$0.19 in 2025, then surged by 47.3% to -$0.1 in 2026.
- Business Quant data shows CGTX's EPS (Basic) at -$0.1 in Q1 2026, -$0.19 in Q4 2025, and -$0.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | 0.18 |
| 10 | Cognition Therapeutics | 89.75 Mn | 89.75 Mn | - | -0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.09 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | -0.22 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.37 |
| Jun 30, 2024 | -0.39 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.51 |
| Sep 30, 2023 | -0.51 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -0.21 |
| Dec 31, 2022 | -0.52 |
| Sep 30, 2022 | -0.29 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.17 |
| Dec 31, 2021 | -2.27 |
| Sep 30, 2021 | -8.12 |